AXSM icon

Axsome Therapeutics

30 hedge funds and large institutions have $33.3M invested in Axsome Therapeutics in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 10 closing their positions.

Holders
30
Holders Change
-5
Holders Change %
-14.29%
% of All Funds
0.75%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
6
Reduced
8
Closed
10
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Bank of America
26
Bank of America
North Carolina
$1K -$18.4K -4,156 -95%
UBS Group
27
UBS Group
Switzerland
$1K -$4.76K -1,142 -83%
BNP Paribas Financial Markets
28
BNP Paribas Financial Markets
France
$17
SCM
29
Sio Capital Management
New York
-$880K -160,000 Closed
Goldman Sachs
30
Goldman Sachs
New York
-$372K -67,618 Closed
ECM
31
Element Capital Management
New York
-$338K -61,510 Closed
PP
32
Paloma Partners
Connecticut
-$269K -48,900 Closed
LP
33
LMR Partners
United Kingdom
-$206K -37,506 Closed
Susquehanna International Group
34
Susquehanna International Group
Pennsylvania
-$188K -34,238 Closed
CS
35
Credit Suisse
Switzerland
-$93K -16,953 Closed
Manulife (Manufacturers Life Insurance)
36
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$3K -492 Closed
WAS
37
Winch Advisory Services
Wisconsin
-$2K -300 Closed